Edition:
United States

Inovalon Holdings Inc (INOV.OQ)

INOV.OQ on NASDAQ Stock Exchange Global Select Market

11.75USD
14 Aug 2018
Change (% chg)

-- (--)
Prev Close
$11.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
98,290
52-wk High
$17.80
52-wk Low
$8.90

Latest Key Developments (Source: Significant Developments)

Inovalon Announces New Post Acute Care Services Agreement With Tenet Healthcare
Wednesday, 28 Mar 2018 07:55am EDT 

March 28 (Reuters) - Inovalon Holdings Inc ::INOVALON ANNOUNCES NEW POST ACUTE CARE SERVICES AGREEMENT WITH TENET HEALTHCARE.ENTERS AGREEMENT WITH TENET HEALTHCARE TO PROVIDE DATA, ANALYTICS, AND TECHNOLOGY PLATFORMS WITHIN POST-ACUTE CARE SERVICES MARKET.‍VANTAGE SOLUTION IS BEING MADE AVAILABLE AS A MODULAR, CONFIGURABLE COMPONENT OF INOVALON ONE PLATFORM​.‍FOLLOWING PENDING ABILITY NETWORK DEAL, VANTAGE WILL BE MADE AVAILABLE AS AN APPLICATION WITHIN MYABILITY SOFTWARE PLATFORM​.  Full Article

Inovalon To Acquire ABILITY Network For ‍$1.2 Billion
Wednesday, 7 Mar 2018 07:00am EST 

March 7 (Reuters) - Inovalon Holdings Inc :​:INOVALON TO ACQUIRE ABILITY NETWORK.INOVALON HOLDINGS - DEAL FOR ‍AGGREGATE CONSIDERATION OF $1.2 BILLION IN CASH AND RESTRICTED STOCK​ .‍TRANSACTION IS EXPECTED TO BE ACCRETIVE TO INOVALON'S NON-GAAP DILUTED NET INCOME PER SHARE IN 2018​.DEAL FOR $1.2 BILLION, COMPRISED OF $1.1 BILLION IN CASH AND $100 MILLION IN RESTRICTED INOVALON STOCK​.‍ WILL FINANCE DEAL THROUGH 7.6 MILLION SHARES OF RESTRICTED EQUITY, CASH ON HAND, AND BORROWINGS FROM A NEW $980 MILLION TERM LOAN​.‍MORGAN STANLEY SENIOR FUNDING, INC. IS PROVIDING FINANCING COMMITMENT FOR ACQUISITION AND WILL LEAD FINANCING​.SEES ‍ 2018 REVENUE $568 MILLION TO $593 MILLION​.SEES ‍2018 DILUTED NET LOSS PER SHARE OF $0.03 TO NET INCOME PER SHARE OF $0.02​.SEES ‍ 2018 NON-GAAP EARNINGS PER SHARE $0.36 TO $0.42​.INOVALON HOLDINGS - ‍CO WILL CONTINUE TO HAVE STRONG LIQUIDITY WITH ABOUT $75 MILLION IN CASH, A PRO-FORMA NET DEBT TO ADJUSTED EBITDA RATIO OF ABOUT 4.1X AT YEAR-END 2018​.DEAL UNANIMOUSLY APPROVED BY INOVALON AND ABILITY BOARDS​.DEAL IS NOT SUBJECT TO A FINANCING CONTINGENCY OR APPROVAL BY CO'S STOCKHOLDERS​.FY2018 EARNINGS PER SHARE VIEW $0.34 -- THOMSON REUTERS I/B/E/S.  Full Article

Inovalon Q4 Non-GAAP EPS $0.06
Tuesday, 20 Feb 2018 04:10pm EST 

Feb 20 (Reuters) - Inovalon Holdings Inc ::INOVALON REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS.Q4 NON-GAAP EARNINGS PER SHARE $0.06.Q4 REVENUE ROSE 19 PERCENT TO $114.6 MILLION.Q4 EARNINGS PER SHARE $0.12.Q4 EARNINGS PER SHARE VIEW $0.07, REVENUE VIEW $116.0 MILLION -- THOMSON REUTERS I/B/E/S.INOVALON - CFO CHRISTOPHER GREINER HAS ACCEPTED NEW OPPORTUNITY OUTSIDE CO.INOVALON - GREINER WILL REMAIN WITH CO UNTIL MARCH 16.INOVALON - JONATHAN BOLDT HAS BEEN NAMED INTERIM CFO UNTIL PERMANENT REPLACEMENT FOR GREINER IS NAMED.SEES 2018 EARNINGS PER SHARE $0.09 TO $0.11.SEES 2018 ADJUSTED EARNINGS PER SHARE $0.31 TO $0.35.SEES 2018 REVENUE $462 MILLION TO $482 MILLION.FY2018 EARNINGS PER SHARE VIEW $0.36, REVENUE VIEW $486.3 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Inovalon Sees Q4 Income Before Taxes Between $3 Mln To $6 Mln
Monday, 8 Jan 2018 07:00am EST 

Jan 8 (Reuters) - Inovalon Holdings Inc ::INOVALON EXPECTS FOURTH QUARTER REVENUE GROWTH OF 18% TO 20% AND ADJUSTED EBITDA GROWTH OF 78% ASSUMING THE MIDPOINT, CONSISTENT WITH PRIOR GUIDANCE.SEES Q4 REVENUE $113.5 MILLION TO $115 MILLION.SEES FY REVENUE $448.2 MILLION TO $449.7 MILLION.- Q4 INCOME BEFORE TAXES EXPECTED TO BE BETWEEN $3.0 MILLION TO $6.0 MILLION.Q4 REVENUE VIEW $118.0 MILLION -- THOMSON REUTERS I/B/E/S.FY2017 REVENUE VIEW $452.3 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Inovalon Holdings reports Q3 earnings per share of $0.06
Wednesday, 1 Nov 2017 04:10pm EDT 

Nov 1 (Reuters) - Inovalon Holdings Inc -:Inovalon reports third quarter 2017 results.Q3 non-gaap earnings per share $0.09.Q3 earnings per share $0.06.Q3 revenue $115.9 million versus I/B/E/S view $114.9 million.Q3 earnings per share view $0.08 -- Thomson Reuters I/B/E/S.Sees Q3 2017 revenue $115.9 million.Sees Q3 2017 revenue up 10 percent.Sees FY non-gaap diluted net income per share $0.30 to $0.33‍​.  Full Article

Inovalon enters into agreement with Daiichi Sankyo Inc
Thursday, 21 Sep 2017 07:55am EDT 

Sept 21 (Reuters) - Inovalon Holdings Inc :Inovalon announces agreement with daiichi sankyo, inc. To support outcomes-based contracting.Inovalon Holdings -entered into agreement with Daiichi Sankyo to understand potential role of abuse-deterrent formulations of opioid medications.  Full Article

Inovalon Holdings says ‍UnitedHealthcare has entered into a 5-year engagement with co​
Tuesday, 12 Sep 2017 07:55am EDT 

Sept 12 (Reuters) - Inovalon Holdings Inc :Inovalon Holdings Inc - ‍UnitedHealthcare has entered into a five-year engagement with co​.  Full Article

Inovalon Holdings Q2 EPS $0.04
Wednesday, 2 Aug 2017 04:10pm EDT 

Aug 2 (Reuters) - Inovalon Holdings Inc ::Reports Q2 2017 revenue $110.6 million.Inovalon reports second quarter 2017 results.Q2 Non-GAAP earnings per share $0.08.Q2 earnings per share $0.04.Q2 revenue $110.6 million versus I/B/E/S view $108.7 million.Q2 earnings per share view $0.07 -- Thomson Reuters I/B/E/S.Says‍ expect approximately 17% year-over-year revenue growth in H2 2017 at midpoint of updated guidance.​Says company expects to see double-digit year-over-year revenue growth in second half of 2017​.Inovalon Holdings inc sees ‍full-year 2017 revenue $447.1 million to $459.3 million​.FY2017 revenue view $445.8 million -- Thomson Reuters I/B/E/S.Inovalon Holdings inc sees ‍ full-year 2017 diluted net income per share $0.13 to $0.16​.FY2017 earnings per share view $0.30 -- Thomson Reuters I/B/E/S.Inovalon Holdings Inc sees ‍full-year 2017 Non-GAAP diluted net income per share $0.29 to $0.32​.Says on July 6, 2017, acquired Complex Care Solutions for approximately $3 million in cash and assumption of a similar amount of debt​.Says‍ expected that acquisition of CCS will contribute an incremental $6 million in revenue during second half of 2017.Says‍ expected that acquisition of CCS will negatively impact adjusted EBITDA by approximately $2.5 million during second half of 2017​.Says‍ company expects acquisition of CCS to be accretive to earnings in 2018​.  Full Article

Amgen enters into agreement with Inovalon and Avalere
Wednesday, 29 Mar 2017 07:55am EDT 

Inovalon Holdings Inc : Amgen enters into agreement with Inovalon and Avalere to engage value-based contracting opportunities . Inovalon Holdings Inc - agreement will focus specifically on Rheumatoid Arthritis (RA) . Inovalon Holdings - Co, Avalere Health will deploy data, analytics capabilities with OBCS to support development of obcs based on value of Amgen's products .Inovalon Holdings - co, Avalere Health, an Inovalon Company, will deploy data, to support further development of OBCS based on value of Amgen's products.  Full Article

Inovalon Q4 non-GAAP earnings per share $0.05
Wednesday, 22 Feb 2017 04:10pm EST 

Inovalon Holdings Inc : Inovalon reports fourth quarter and full year 2016 results . Q4 non-GAAP earnings per share $0.05 . Q4 earnings per share $0.00 . Q4 revenue $96.1 million versus $120.6 million . Sees FY 2017 non-gaap earnings per share $0.28 to $0.31 . Sees FY 2017 earnings per share $0.13 to $0.16 . Sees FY 2017 revenue $440.5 million to $455 million .Inovalon Holdings Inc sees full-year 2017 adjusted EBITDA is expected to be between $105.2 million and $112.5 million.  Full Article